AU3456499A - Isoflavones for treating giardiasis and malaria - Google Patents

Isoflavones for treating giardiasis and malaria

Info

Publication number
AU3456499A
AU3456499A AU34564/99A AU3456499A AU3456499A AU 3456499 A AU3456499 A AU 3456499A AU 34564/99 A AU34564/99 A AU 34564/99A AU 3456499 A AU3456499 A AU 3456499A AU 3456499 A AU3456499 A AU 3456499A
Authority
AU
Australia
Prior art keywords
isoflavones
malaria
treating giardiasis
giardiasis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34564/99A
Inventor
Mitchell A Avery
Charles L. Burandt
D. Keith Goins
Ikhlas A. Khan
Larry A. Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Mississippi
Original Assignee
University of Mississippi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Mississippi filed Critical University of Mississippi
Publication of AU3456499A publication Critical patent/AU3456499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU34564/99A 1998-03-30 1999-03-30 Isoflavones for treating giardiasis and malaria Abandoned AU3456499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5073498A 1998-03-30 1998-03-30
US09050734 1998-03-30
PCT/US1999/006904 WO1999049862A1 (en) 1998-03-30 1999-03-30 Isoflavones for treating giardiasis and malaria

Publications (1)

Publication Number Publication Date
AU3456499A true AU3456499A (en) 1999-10-18

Family

ID=21967078

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34564/99A Abandoned AU3456499A (en) 1998-03-30 1999-03-30 Isoflavones for treating giardiasis and malaria

Country Status (2)

Country Link
AU (1) AU3456499A (en)
WO (1) WO1999049862A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555523B1 (en) 1999-07-08 2003-04-29 Patrick T. Prendergast Use of cirsiliol and derivatives to treat infections
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
US7468445B2 (en) 2002-08-07 2008-12-23 University Of Mississippi Antigiardial agents and use thereof
AU2002951833A0 (en) * 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
AU2003265737B2 (en) * 2002-10-02 2008-10-16 Novogen Research Pty Ltd Combination chemotherapy compositions and methods
ATE532777T1 (en) 2004-09-21 2011-11-15 Marshall Edwards Inc SUBSTITUTED CHROMEDER DERIVATIVES, MEDICATIONS AND APPLICATIONS IN THERAPY
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
MX2012012354A (en) * 2010-04-23 2013-03-07 Kineta Inc Anti-viral compounds.
EP2635121B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
US9458492B2 (en) 2011-02-25 2016-10-04 Kineta, Inc. Methods and cells for identifying RIG-I pathway regulators
PL3253208T3 (en) 2015-02-02 2021-11-08 Mei Pharma, Inc. Combination therapies for use in the treatment of breast cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064550A1 (en) * 1991-04-01 1992-10-02 Marilyn Parsons Tyrosine phosphorylation in protozoans
USRE40792E1 (en) * 1992-05-19 2009-06-23 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
CA2160371A1 (en) * 1993-04-16 1994-10-27 The Trustees Of Tufts College Method for treatment of menopausal and premenstrual symptoms

Also Published As

Publication number Publication date
WO1999049862A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
AU6733198A (en) Authentication method
AU6111699A (en) Novel method and compounds
AU4431999A (en) Neuro-parity pattern recognition system and method
AU2001237030A1 (en) Method and system for content deployment and activation
AU2373200A (en) Apparatuses and methods for forming assemblies
AU6629400A (en) Authentication system and method
AU6420699A (en) Document facing method and apparatus
AU6589798A (en) Ileus treatment method
AU1595900A (en) Anti-cancer compounds and methods related thereto
AU6268899A (en) Systems and methods for treating ischemia
AU3970899A (en) Ferrographic method and apparatus
AU3869200A (en) Method and composition for masking mineral taste
AU2001279850A1 (en) Method and arrangement for studsystem
AU3456499A (en) Isoflavones for treating giardiasis and malaria
AU3488699A (en) Surface treatment process and system
AU2592299A (en) Sailboats and methods
AUPP433398A0 (en) Compounds and processes
AU2001218024A1 (en) Methods for treating and preventing alopecia
AU5215399A (en) Microscopy method and apparatus
AU7694200A (en) Method and arrangement for communications security
AU1734801A (en) Processes for producing tetrahydropyranyl-4-sulfonate and 4-aminotetrahydropyrancompound
AU6819598A (en) Anti-counterfeit method and product using the method
AUPP679398A0 (en) Karyotyping means and method
AU2001243297A1 (en) Method for treating or preventing depression
AU2935699A (en) Process for the decoration of wall-tiles and floor-tiles

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase